Biology subjects

Abel-Santos, E.

Publications and source records attributed to Abel-Santos, E..

10 recordsLinked to original sources

bioRxiv2026

Novel bile salt analogs reduce lipid accumulation in liver cells with potential to treat both metabolic dysfunction-associated steatotic liver disease and Clostridioides difficile infection

Metabolic dysfunction-associated steatotic liver disease (MASLD) and Clostridioides difficile (C. difficile) infection (CDI) are clinically associated, yet there is limited effective treatment for both diseases. Bile salt analogs (BSAs) have demonstrated potential in treating either MASLD or CDI. We screened a library of BSAs (n=112) previously synthesized as potential inhibitors of C. difficile spore germination, for their therapeutic potential in reducing intracellular accumulation of fatty acids in HepG2 cells as candidates for prevention and treatment of both MASLD and CDI. The screening was based on an in vitro model established by incubating HepG2 cells with free fatty acids, with obeticholic acid (OCA), a known BSA with anti-MASLD activity as a control. Gene and protein expressions were quantified to validate the treatment effect. We found that compounds C13, C24, C25, C74, C98, and C101 demonstrated significant effectiveness in both preventing the intracellular accumulation of lipids and removing pre-loaded cellular lipids. Gene expression analysis showed that C24, C25, and C74 produced a similar pattern characterized by a robust induction of FGF21 expression, while C13, C98, and C101 produced a transcription pattern that mirrors the effect of OCA. Structurally, while C13, C24, and C25 do not display drug-like properties, C74, C98, and C101 are drug-like and share a similar structure. Interestingly, C101 is a potent inhibitor of C. difficile spore germination. OCA shows a weak anti-gemination effect. Our study identified lead compound candidates for the development of novel therapeutics capable of treating both MASLD and CDI. Significance statementThe clinical association between MASLD and CDI remains an unmet need for dual acting therapeutic strategies. Given the reported potential of BSA, we screened 112 previously synthesized as potential inhibitors of C. difficile spore germination, for their therapeutic potential in reducing intracellular accumulation of fatty acids in HepG2 cells. Our study identified compounds that effectively reduce intracellular lipid accumulation and inhibit C. difficile spore germination. These results nominate lead candidates for developing dual-acting therapeutics targeting both MASLD and CDI.

pharmacology and toxicology↗

bioRxiv2025

Effects of dipicolinic acid on Bacillus anthracis spore biology and cytotoxicity

Bacillus anthracis is a gram-positive spore-forming bacterium that causes lethal inhalation anthrax. The use of B. anthracis as a bioweapon is predicated in its ability to form dormant and resistant infective spores that can be used as agents. B. anthracis spores contain large concentrations of dipicolinic acid complexed with cations, especially calcium (Ca-DPA). Following phagocytosis by alveolar macrophages, spores germinate inside the phagolysosome and excrete the Ca-DPA depot into the phagosomal space. In this study, we assessed the effects of DPA on B. anthracis spore biology and cytotoxicity. We generated B. anthracis mutants with defects in DPA synthesis ({Delta}spoVFA, {Delta}spoVFB, {Delta}spoVFAB) or transport ({Delta}spoVV). To increase the viability of DPA-less spores, we also constructed double mutants ({Delta}sleB{Delta}spoVFA, {Delta}sleB{Delta}spoVFB, {Delta}sleB{Delta}spoVFAB and{Delta} sleB{Delta}spoVV) by deleting the cortex lytic sleB gene. We found that single- and double-mutant DPA-less spores were profoundly compromised in dormancy, viability, germination, and heat resistance. Contrary to expectations, each DPA synthesis mutant exhibited distinct viability and resistance phenotypes. Even with compromised stability, DPA-less B. anthracis spores, with the exception of the {Delta}sleB{Delta}spoVV double mutant, were as cytotoxic as wild-type spores. In summary, DPA is required to sustain normal B. anthracis spore biology but is not required for macrophage-targeted virulence. Furthermore, the SpoVV transporter and SleB lytic protein seem to have redundant roles in anthrax spore cytotoxicity beyond DPA accumulation. ImportanceBacillus anthracis causes deadly pulmonary anthrax and has been used as a weapon for bioterrorism. B. anthracis form spores that germinate and establish infection. During germination, B. anthracis spores release large amounts of calcium complexed with dipicolinic acid (DPA). In this study, we deleted the B. anthracis genes that are required to synthesize and transport DPA into spores. We found that B. anthracis DPA-less mutant spores exhibited differential biological effects that were DPA independent. Furthermore, we found that DPA was not required for anthrax cytotoxicity. Finally, we found that proteins involved in DPA synthesis, transport, and cortex lysis have biological and virulence functions that extend beyond DPA accumulation.

microbiology↗

bioRxiv2025

Effects of sexual dimorphism and estrous cycle on C. difficile infections prophylaxis in two rodent models

Clostridioides difficile infection (CDI) is responsible for the majority of identifiable hospital-related antibiotic-associated diarrhea. Susceptibility to CDI and severity of disease varies depending on a variety of factors such as aggressive use of broad-spectrum antibiotics, age, and immune status. Epidemiological studies have consistently shown that female patients are more at risk for CDI than their male counterparts. C. difficile is spread by spores which can persist in the environment and in the intestines of patients. Spores do not cause disease but germinate in the antibiotic-altered gut of patients to generate toxin producing vegetative cells. The germination of C. difficile spores is mediated by the composition of bile salts in the gut with taurocholate facilitating germination and chenodeoxycholate inhibiting it.

microbiology↗

bioRxiv2025

Nutrient requirements for cell differentiation progression in Batrachochytrium dendrobatidis

Batrachochytrium dendrobatidis (Bd) is the causative agent of the deadly amphibian disease chytridiomycosis, which has decimated amphibian populations across the globe. Bd reproduces via a multistage asexual pathway. The Bd life cycle begins with a motile zoospore. Upon contact with a surface, the zoospore anchors itself and forms a cyst. The cyst then develops into a germling that produces rhizoid structures. Finally, the germling matures into a zoosporangium which then releases multiple new zoospores. In this study, we investigated the effects of nutrients on the growth and differentiation of Bd. The presence of carbohydrates, vitamins, and trace minerals had a negligible effect on Bds ability to progress through its life cycle. In contrast, the amino acids L-leucine and L-isoleucine (and to a lesser extent L-arginine) were required for cysts to germinate into germlings. However, none of these amino acids were able to sustain further cellular development. Furthermore, the presence of nitrate or ammonium aided progression from germlings into immature zoosporangia that were not able to produce zoospores. The progression to mature zoosporangia was blocked by nitrite or the combined action of calcium ions and bicarbonate. The addition of soluble and insoluble protein sources alone also allowed Bd to develop into immature zoosporangia and affected the rate of development. Finally, protein sources in combination with L-amino acids allowed the completion of the Bd cycle by allowing development from zoospores to mature zoosporangia that were able to release new zoospores. ImportanceEven though the cell differentiation cycle of Bd has been microscopically described, not much is known about the requirements for Bd to progress throughout its life stages. The identification of the molecular cues that allow Bd cell cycle progression may be crucial to disease mitigation efforts. As a corollary, we have identified conditions that allow for the arrest of Bd at various stages of its life cycle. By changing the metabolite availability, we can efficiently obtain cultures enriched for zoospores, cysts, germlings, immature zoosporangia, or spore-releasing zoosporangia. The ability to temporarily freeze and then restart Bd at different points of its life cycle, can allow for determining the mechanisms behind individual transitions between cell types.

microbiology↗

bioRxiv2025

Murine model of antibiotic-associated S. aureus gastrointestinal infections (SAGII) and colonization

BackgroundStaphylococcus aureus is an opportunistic pathogen that can both colonize the gastrointestinal tract and cause antibiotic associated diarrhea. MethodsTo develop a robust murine model for S. aureus gastrointestinal infection (SAGII) and colonization, mice were (a) treated with varying antibiotic regimes prior to infection, (b) infected with either a methicillin-sensitive S. aureus (MSSA) or a methicillin-resistant S. aureus (MRSA) strain, (c) challenged with different bacterial inocula, (d) tested for sexual dimorphism of SAGII virulence, and (e) tested for macronutrient effects on SAGII onset and virulence. ResultsWe found that antibiotic-treated male mice (but not female mice) were highly susceptible to even low inoculums of both an MSSA and an MRSA strains. Interestingly, male mice challenged with an MSSA strain showed more severe and more prolonged SAGII symptomatology than animals challenged with an MRSA strain. We also showed that for male mice a high-carbohydrate diet and a high-fat diet led to asymptomatic intestinal colonization followed by delayed SAGII sign onset. In contrast, male mice fed a high-protein diet started developing mild SAGII signs early but did not develop severe SAGII until two weeks post-challenge. Furthermore, only the high-protein diet sensitized female mice to SAGII, but their symptomatology remained less severe than in male mice. ConclusionsWe developed a robust murine model for antibiotic-associated S. aureus gastrointestinal infection and colonization. This model shows both sexual dimorphism and macronutrient preference for SAGII severity. Diet manipulation can also be used to establish S. aureus colonization of the GI tract.

microbiology↗

bioRxiv2023

Effects of sexual dimorphism and estrous cycle on C. difficile infections in rodent models

Clostridioides difficile infection (CDI) is responsible for the majority of identifiable antibiotic-associated diarrhea. Women are more susceptible to CDI than men. In this study, we show that female mice developed more severe CDI than males. Furthermore, females in estrus developed only mild CDI 1-2 days later, while females in proestrus developed deadly disease. Mirroring the delayed effect of the estrous cycle, pre-infection prolactin levels formed a complex network with immunoglobulins and cytokines that affected early CDI severity one day after challenge. Similarly, pre-infection progesterone and luteinizing hormone formed a network that affected CDI two days after challenge. As expected, immune effectors early in the infection formed a hormone-independent network that concurrently correlated with CDI severity. Interestingly, early infection follicular stimulating hormone levels created a network that affected the CDI recovery phase. In summary, murine sexual hormones affect CDI progression by affecting the immune system both before and during disease progression.

microbiology↗

bioRxiv2023

Mechanism of germination inhibition of Clostridioides difficile spores by an aniline substituted cholate derivative (CaPA)

Clostridioides difficile infection (CDI) is the major identifiable cause of antibiotic-associated diarrhea and has been declared an urgent threat by the CDC. C. difficile forms dormant and resistant spores that serve as infectious vehicles for CDI. To cause disease, C. difficile spores recognize taurocholate and glycine to trigger the germination process. In contrast to other sporulating bacteria, C. difficile spores are postulated to use a protease complex, CspABC, to recognize its germinants. Since spore germination is required for infection, we have developed anti-germination approaches for CDI prophylaxis. Previously, the bile salt analog CaPA (an aniline-substituted cholic acid) was shown to block spore germination and protect rodents from CDI caused by multiple C. difficile strains. In this study, we found that CaPA is an alternative substrate inhibitor of C. difficile spore germination. By competing with taurocholate for binding, CaPA delays C. difficile spore germination and reduces spore viability, thus diminishing the number of outgrowing vegetative bacteria. We hypothesize that the reduction of toxin-producing bacterial burden explains CaPAs protective activity against murine CDI. Previous data combined with our results suggests that CaPA binds tightly to C. difficile spores in a CspC-dependent manner and irreversibly trap spores in an alternative, time-delayed, and low yield germination pathway. Our results are also consistent with kinetic data suggesting the existence of at least two distinct bile salt binding sites in C. difficile spores.

microbiology↗

bioRxiv2023

Comparison of sporulation and germination conditions for Clostridium perfringens strains

Clostridium perfringens is a spore forming, obligate anaerobe, Gram-positive bacterium that causes a range of diseases in humans and animals. The infectious form of C. perfringens is the spore, a structure that is derived from the vegetative cell under conditions of nutrient deprivation. The first step in C. perfringens pathogenesis is the differentiation of spores into replicating bacteria. Previous work in analyzing C. perfringens spore germination has produced contradictory, strain-specific results. Hence, we analyzed the requirements for spore formation and germination in seven different C. perfringens strains. Our data showed that C. perfringens sporulation conditions are strain specific, but germination responses are homogenous. C. perfringens spores can germinate using two distinct pathways. The first germination pathway (the amino acid-only pathway or AA) requires L-alanine, L-phenylalanine, and sodium ions (Na+) as co-germinants. L-arginine is not a required germinant but potentiates germination. The AA pathway is inhibited by aromatic amino acids and potassium ions (K+). Bicarbonate (HCO3-), on the other hand, bypasses potassium-mediated inhibition of C. perfringens spore germination through the AA pathway. The second germination pathway (the bile salt and amino acid pathway or BA) is more promiscuous and is activated by several bile salts and amino acids. In contrast to the AA pathway, the BA pathway is insensitive to Na+, but can be activated by either K+ or HCO3-. We hypothesize that C. perfringens may have evolved these two distinct germination pathways to ensure spore response to different host environments. Manuscript contribution to the fieldClostridium perfringens is a ubiquitous bacterium that can infect a wide variety of animal hosts, including humans. C. perfringens counts with a veritable arsenal of toxins that are differentially expressed depending on the host infected. Besides toxin production, C. perfringens can also form dormant and resistant spores that serve as infective vehicles. C. perfringens spores need to germinate back into vegetative cells to cause disease. Befitting to its wide host range, C. perfringens spore germination seems to use strain specific. In this study, we tested the ability of seven C. perfringens strains to produce spores under different conditions. We also tested the requirements for spore germination. We found that while C. perfringens sporulation was highly varied, the germination response for all strains could be divided into two distinct pathways. Since C. perfringens spores need to germinate to cause infection, understanding the germination behavior could lead to approaches for the prevention of diseases in humans and veterinary animals.

microbiology↗

bioRxiv2021

A high-carbohydrate diet prolongs dysbiosis and Clostridioides difficile carriage and increases late-onset CDI and mortality in a hamster model of infection

Studies using mouse models of Clostridioides difficile infection (CDI) have demonstrated a variety of relationships between dietary macronutrients on antibiotic-associated CDI; however, few of these effects have been examined in hamster models of CDI. In this study, we investigated the effect of a high-carbohydrate diet previously shown to protect mice from CDI on the progression and resolution of CDI in a hamster disease model. Hamsters fed the high-carbohydrate diet developed distinct diet-specific microbiomes during antibiotic treatment and CDI, with lower diversity, persistent C. difficile carriage, and delayed microbiome restoration. In contrast to 0% mortality in mice, 80% of hamsters fed the high-carbohydrate diet developed fulminant CDI and died, including several cases of late-onset CDI, whereas only 33% of hamsters fed a standard lab diet developed CDI only during the acute phase. We speculate that prolonged dysbiosis in these animals allowed C. difficile to proliferate following a three-day vancomycin course administered as part of this model system, leading to secondary CDI and eventual mortality. This study, along with similar studies in mouse models of CDI, suggests high-carbohydrate diets promote antibiotic-associated dysbiosis and long-term C. difficile carriage, which may convert to symptomatic CDI when conditions change. ImportanceThe effects of diet on CDI are not completely known, although most studies in mouse CDI models show that dietary carbohydrates ameliorate CDI. Here, we used a high-carbohydrate diet previously shown to protect mice against CDI to assess its effect on a hamster model of CDI and paradoxically found that it promoted dysbiosis, C. difficile carriage, and higher mortality. A common thread in both mouse and hamster experimental models was that the high-carbohydrate diet promoted long-term carriage of C. difficile, which may have converted to fulminant CDI only in the highly susceptible hamster model system. If diets high in carbohydrates also promote dysbiosis and C. difficile carriage in humans, then these diets might paradoxically increase chances of CDI relapse despite their protective effects against primary CDI.

microbiology↗

bioRxiv2019

A high-fat/high-protein, Atkins-type diet exacerbates Clostridioides (Clostridium) difficile infection in mice, whereas a high-carbohydrate diet protects

Clostridioides difficile (formerly Clostridium difficile) infection (CDI) can result from the disruption of the resident gut microbiota. Western diets and popular weight-loss diets drive large changes in the gut microbiome; however, the literature is conflicted with regard to the effect of diet on CDI. Using the hypervirulent strain C. difficile R20291 (RT027) in a mouse model of antibiotic-induced CDI, we assessed disease outcome and microbial community dynamics in mice fed two high-fat diets in comparison with a high-carbohydrate diet and a standard rodent diet. The two high-fat diets exacerbated CDI, with a high-fat/high-protein, Atkins-like diet leading to severe CDI and 100% mortality, and a high-fat/low-protein, medium-chain triglyceride (MCT)-like diet inducing highly variable CDI outcomes. In contrast, mice fed a high-carbohydrate diet were protected from CDI, despite high refined carbohydrate and low fiber content. 28 members of the Lachnospiraceae and Ruminococcaceae decreased in abundance due to diet and/or antibiotic treatment; these organisms may compete with C. difficile for amino acids and protect healthy animals from CDI in the absence of antibiotics. Together, these data suggest that antibiotic treatment might lead to loss of C. difficile competitors and create a favorable environment for C. difficile proliferation and virulence that is intensified by high-fat/high-protein diets; in contrast, high-carbohydrate diets might be protective regardless of the source of carbohydrate.

microbiology↗